Okemos, MI, United States of America

Aitor Aguirre

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Michigan State University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aitor Aguirre. Retrieved from https://idiyas.com/inventor/aitor-aguirre-svbnyb2e

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aitor Aguirre: Innovator in Heart Organoid Technology

Introduction

Aitor Aguirre is a prominent inventor based in Okemos, MI (US). He has made significant contributions to the field of regenerative medicine, particularly in the development of heart organoids derived from pluripotent stem cells. His innovative work aims to advance our understanding of cardiac biology and potential therapeutic applications.

Latest Patents

Aguirre holds a patent for a method of generating a heart organoid. This method involves forming a cellular aggregate of pluripotent stem cells, activating Wnt signaling to differentiate the aggregate into a three-dimensional cardiac mesoderm, and subsequently inhibiting Wnt signaling to form the heart organoid. The resulting heart organoid contains myocardial tissue, endocardial tissue defining at least one chamber, and epicardial tissue on the outer surface of the myocardial tissue. Notably, the heart organoid is capable of beating, showcasing its functional characteristics. He has 1 patent related to this groundbreaking technology.

Career Highlights

Aguirre is affiliated with Michigan State University, where he conducts research and collaborates with other scientists in the field. His work is pivotal in exploring new avenues for heart disease treatment and regenerative therapies.

Collaborations

Aguirre collaborates with Yonatan Raz Israeli, contributing to the advancement of heart organoid research and its applications in medicine.

Conclusion

Aitor Aguirre's innovative work in developing heart organoids represents a significant advancement in regenerative medicine. His contributions have the potential to transform the landscape of cardiac research and therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…